Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer
NCT07088263
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
192
Enrollment
OTHER
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
Gemcitabine, Vinorelbine, Eribulin, or Utidelone
Sponsor
Sun Yat-sen University